Prevalence and Clinical Severity of Cutaneous Lupus Erythematosus
The Cutaneous Lupus Erythematosus (CLE) database, established in 2006, is a multi-site database between the University of Pennsylvania and the University of Texas Southwestern (UTSW).
Conditions:
🦠 Cutaneous Lupus Erythematosus (CLE)
🗓️ Study Start (Actual) December 2006
🗓️ Primary Completion (Estimated) 2 January 2025
✅ Study Completion (Estimated) 2 January 2025
👥 Enrollment (Estimated) 700
🔬 Study Type OBSERVATIONAL
📊 Phase N/A
Locations:
📍 Philadelphia, Pennsylvania, United States
📍 Dallas, Texas, United States

📋 Eligibility Criteria

Description

    Inclusion Criteria:

    • * Subjects who meet the criteria for having CLE, using the Gilliam classifications, and/or a diagnosis of systemic lupus erythematosus (SLE), using the American Rheumatism Association/American College of Rheumatology criteria. Subjects must be 18 years or older.

    Exclusion Criteria:

    • * All subjects who do not meet the criteria for having CLE. Subjects who meet the criteria for CLE but who are not yet 18 years old
Ages Eligible for Study: 18 Years to N/A (ADULT, OLDER_ADULT)
Sexes Eligible for Study: ALL
Accepts Healthy Volunteers: No

🗓️ Study Record Dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Registration Dates

  • First Submitted 10 January 2012
  • First Submitted that Met QC Criteria 12 January 2012
  • First Posted 13 January 2012

Study Record Updates

  • Last Update Submitted that Met QC Criteria 2 April 2024
  • Last Update Posted 4 April 2024
  • Last Verified April 2024